Simulations Plus to Report First Quarter Fiscal Year 2019 Financial Results
January 02 2019 - 8:30AM
Business Wire
Conference Call to be on Wednesday, January
9, 2019, at 4:15 p.m. EST
Simulations Plus, Inc. (Nasdaq: SLP), announced today that it
will report its first quarter financial results for fiscal year
2019, the period ended November 30, 2018, after the close of the
financial markets on Wednesday, January 9, 2019.
The Company invites all interested persons to attend its
conference call at 4:15 p.m. Eastern Time on January 9, 2019. The
live webcast/teleconference will be accessible by registering here.
Please dial in five to ten minutes prior to the scheduled start
time. A live, listen-only webcast will also be available by dialing
(914) 614-3221, and entering access code 793-421-673. A replay of
the webcast will be available at the Investors section of the
Simulations Plus website following the call.
About Simulations Plus, Inc.
Simulations Plus, Inc., is a premier developer of drug discovery
and development software as well as a leading provider of both
preclinical and clinical pharmacometric consulting services for
regulatory submissions and quantitative systems pharmacology models
for drug-induced liver injury and nonalcoholic fatty liver disease.
The company is a global leader focused on improving the ways
scientists use knowledge and data to predict the properties and
outcomes of pharmaceutical, biotechnology, and chemical agents. Our
software is licensed to and used in the conduct of drug research by
major pharmaceutical, biotechnology, chemical, and consumer goods
companies and regulatory agencies worldwide. Our innovations in
integrating new and existing science in medicinal chemistry,
computational chemistry, pharmaceutical science, biology, and
physiology into our software have made us the leading software
provider for physiologically based pharmacokinetic modeling and
simulation. For more information, visit our website at
www.simulations-plus.com.
Follow us on Twitter | LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190102005178/en/
Simulations Plus Investor
RelationsMs. Renee
Bouche661-723-7723renee@simulations-plus.com
Hayden IRMr. Cameron
Donahue651-653-1854cameron@haydenir.com
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Apr 2023 to Apr 2024